“…In both cases, this molecule could reduce the lifetime or number of oligomeric species by catalyzing their conversion to the fibrillar form for Aβ 42 (Limbocker et al, 2019) or attenuating their rate of formation for αS (Perni et al, 2018). Trodusquemine prevents the toxicity of isolated or stabilized oligomers comprised of the 40-residue form of Aβ (Aβ 40 ), Aβ 42 , αS, and the model protein HypF-N by binding to the cell membrane (Errico et al, 2020), outcompeting oligomers at the cell membrane, and therein displacing these aggregates from cell membranes through a conserved mechanism (Perni et al, 2018;Limbocker et al, 2019Limbocker et al, , 2020b. Trodusquemine was found not to directly target either the size or hydrophobicity of the oligomers at physiological concentrations, but instead to function through a mechanism based on oligomer displacement from the cell membrane in addition to its ability to modulate the kinetics of their assembly (Perni et al, 2018;Limbocker et al, 2019Limbocker et al, , 2020b.…”